The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance

被引:9
|
作者
Gregg, Justin R. [1 ]
Surasi, Devaki Shilpa [1 ]
Childs, Alexandria [1 ]
Moll, Nicholas [1 ]
Ward, John F. [1 ]
Kim, Jeri [2 ]
Daniel, Carrie R. [1 ]
Logothetis, Christopher [1 ]
Bathala, Tharakeswara [1 ]
Davis, John W. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Merck & Co Inc, Kenilworth, NJ USA
来源
JOURNAL OF UROLOGY | 2021年 / 205卷 / 01期
关键词
prostatic neoplasms; adipose tissue; prostate; disease progression;
D O I
10.1097/JU.0000000000001321
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Evidence suggests that visceral fat quantity may be associated with post-prostatectomy outcomes and risk of prostate cancer related death. We evaluated whether increased fat volume, normalized to prostate size, is associated with decreased risk of disease progression. Materials and Methods: Patients enrolled on a prospective active surveillance trial for at least 6 months who had magnetic resonance imaging within 2 years of enrollment were eligible. The surveillance protocol included a standardized followup regimen consisting of biennial prostate specific antigen and examination and yearly biopsy. Clinicopathological characteristics were collected at baseline. Three fat measurements were taken using prostate magnetic resonance imaging, including subcutaneous, linear periprostatic (pubic symphysis to prostate) and volumetrically defined periprostatic. Progression was defined as increase in Gleason grade group. Multivariable Cox proportional hazards models were used to evaluate fat volumes normalized by prostate size (stratified into tertiles). Results: A total of 175 patients were included in the study. Average age was 62.5 years (SD 7.4) and average prostate specific antigen was 5.4 ng/dl (SD 3.9). Median followup was 42 months (IQR 18-60) and 50 patients (28.6%) had progression. Compared to the lowest tertile, the highest tertile of volumetric periprostatic fat measurement (HR 2.63, 95% CI 1.23-5.60, p=0.01) and linear periprostatic fat measurement (HR 2.30, 95% CI 1.01-5.22, p=0.05) were associated with worsened progression-free survival, while subcutaneous fat measurement (p=0.97) was not. Importantly, the model did not substantively change when accounting for patient body mass index and other factors. Conclusions: Increased periprostatic fat volume, normalized to prostate size, may be associated with shortened progression-free survival in men with prostate cancer on active surveillance.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [1] Adherence to the Mediterranean diet and grade group progression in localized prostate cancer: An active surveillance cohort
    Gregg, Justin R.
    Zhang, Xiaotao
    Chapin, Brian F.
    Ward, John F.
    Kim, Jeri
    Davis, John W.
    Daniel, Carrie R.
    [J]. CANCER, 2021, 127 (05): : 720 - 728
  • [2] MOLECULAR DISSECTION OF GRADE PROGRESSION IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Tosoian, Jeffrey
    Salami, Simpa
    Nallandhighal, Srinivas
    Jones, Tonye, Jr.
    Brockman, Scott
    Elkhoury, Fuad
    Bazzi, Selena
    Plouffe, Komal
    Sumida, Lauren
    Siddiqui, Javed
    Liu, Chia-Jen
    Kunju, Lakshmi
    Morgan, Todd
    Vince, Randy
    Natarajan, Shyam
    Boonstra, Phil
    Tomlins, Scott
    Udager, Aaron
    Sisk, Anthony
    Marks, Leonard
    Palapattu, Ganesh
    [J]. JOURNAL OF UROLOGY, 2020, 203 : E118 - E119
  • [3] ASSOCIATION OF BASELINE PLASMA CAFFEINE LEVELS AND RELATED METABOLITES WITH TIME TO GRADE GROUP PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Gregg, Justin
    Fahrmann, Johannes
    Wu, Ranran
    Murage, Eunice
    Dennison, Jennifer
    Chapin, Brian
    Davis, John
    Wei, Peng
    Hanash, Samir
    Daniel, Carrie
    [J]. JOURNAL OF UROLOGY, 2021, 206 : E571 - E571
  • [4] PROGRESSION OF PATIENTS WITH LOCALIZED PROSTATE CANCER IN ACTIVE SURVEILLANCE
    Ozkan, T. A.
    Ustuner, M.
    Ozkan, L.
    Saribacak, A.
    Yilmaz, H.
    Muezzinoglu, B.
    Dillioglugil, O.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (06) : 562 - 562
  • [5] RADIOLOGICAL PROGRESSION IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE
    Ridout, Ashley J.
    Stevens, Daniel
    Allen, Clare
    Kirkham, Alex
    Emberton, Mark
    Moore, Caroline M.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E552 - E552
  • [6] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Kelly R. Pekala
    Oskar Bergengren
    James A. Eastham
    Sigrid V. Carlsson
    [J]. BMC Urology, 23
  • [7] Active surveillance should be considered for select men with Grade Group 2 prostate cancer
    Pekala, Kelly R.
    Bergengren, Oskar
    Eastham, James A.
    Carlsson, Sigrid V.
    [J]. BMC UROLOGY, 2023, 23 (01)
  • [8] Active Surveillance in Men With Localized Prostate Cancer A Systematic Review
    Dahabreh, Issa J.
    Chung, Mei
    Balk, Ethan M.
    Yu, Winifred W.
    Mathew, Paul
    Lau, Joseph
    Ip, Stanley
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (08) : 582 - U110
  • [9] The role of MRI in active surveillance for men with localized prostate cancer
    Recabal, Pedro
    Ehdaie, Behfar
    [J]. CURRENT OPINION IN UROLOGY, 2015, 25 (06) : 504 - 509
  • [10] Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance
    de la Calle, Claire M.
    Mamawala, Mufaddal M.
    Landis, Patricia
    Macura, Katarzyna J.
    Trock, Bruce J.
    Epstein, Jonathan I.
    Pavlovich, Christian P.
    [J]. JOURNAL OF UROLOGY, 2023, 209 (01): : 180 - 185